World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
52386
World Ranking
5484
National Ranking
205

Harry J. de Koning publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Harry J. de Koning sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 496 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Harry J. de Koning D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Harry J. de Koning sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 110 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Harry J. de Koning is affiliated with Erasmus University Rotterdam in the Netherlands. Their research primarily focuses on the field of Medicine with an emphasis on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Surgery, and Epidemiology.

The scientist's work covers a range of topics including:

  • Global Cancer Incidence and Screening
  • Lung Cancer Diagnosis and Treatment
  • Colorectal Cancer Screening and Detection
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Digital Radiography and Breast Imaging
  • Chronic Obstructive Pulmonary Disease (COPD) Research

Their publication record includes contributions to frequent venues such as:

  • European Journal of Cancer
  • Journal of Thoracic Oncology
  • International Journal of Cancer
  • JAMA Oncology
  • Radiology

Among recent papers authored by Harry J. de Koning are:

  • "Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial" (2020, New England Journal of Medicine)
  • "Personalized early detection and prevention of breast cancer: ENVISION consensus statement" (2020, Nature Reviews Clinical Oncology)
  • "Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography" (2021, JAMA)
  • "Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases" (2021, Hepatology)
  • "Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review" (2020, European Journal of Cancer)

Frequent co-authors collaborating with de Koning include:

  • Eveline A.M. Heijnsdijk
  • Matthijs Oudkerk
  • Carlijn M. van der Aalst
  • Kevin ten Haaf
  • Nicolien T. van Ravesteyn

Best Publications

  • Screening and Prostate-Cancer Mortality in a Randomized European Study

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

    Harry J. de Koning;Carlijn M. van der Aalst;Pim A. de Jong;Ernst T. Scholten

  • Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition

    Mieke Kriege;Cecile T.M. Brekelmans;Carla Boetes;Peter E. Besnard

  • Prostate-Cancer Mortality at 11 Years of Follow-up

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

    Gerrit Draisma;Rob Boer;Suzie J. Otto;Ingrid W. van der Cruijsen

  • Management of lung nodules detected by volume CT scanning

    Rob J van Klaveren;Matthijs Oudkerk;Mathias Prokop;Ernst T Scholten

  • Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

    Gerrit Draisma;Ruth Etzioni;Alex Tsodikov;Angela Mariotto

  • Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

    Jeanne S. Mandelblatt;Kathleen A. Cronin;Stephanie Bailey;Donald A. Berry

  • Supplemental MRI Screening for Women with Extremely Dense Breast Tissue

    Marije F. Bakker;Stéphanie V. de Lange;Ruud M. Pijnappel;Ritse M. Mann

  • European position statement on lung cancer screening

    Matthijs Oudkerk;Anand Devaraj;Rozemarijn Vliegenthart;Thomas Henzler

  • Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force

    Harry J. de Koning;Rafael Meza;Sylvia K. Plevritis;Kevin ten Haaf

  • A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

    Jonas Hugosson;Monique J. Roobol;Marianne Månsson;Teuvo L.J. Tammela

  • Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening

    Nanda Horeweg;Joost van Rosmalen;Marjolein A Heuvelmans;Carlijn M van der Aalst

  • Quality-of-life effects of prostate-specific antigen screening.

    Eveline A M Heijnsdijk;Elisabeth M Wever;Anssi Auvinen;Jonas Hugosson

  • Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review

    Donella Puliti;Stephen W Duffy;Guido Miccinesi;Harry de Koning

  • Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review.

    Suzie J. Otto;Jacques Fracheboud;Caspar W. N. Looman;Mireille J. M. Broeders

  • Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON)

    Carola A. van Iersel;Harry J. de Koning;Gerrit Draisma;Willem P. T. M. Mali

  • Prostate cancer detection at low prostate specific antigen.

    Fritz H. Schröder;Ingrid van der Cruijsen-Koeter;Harry J. de Koning;André N. Vis

  • Nodule management protocol of the NELSON randomised lung cancer screening trial

    Dong Ming Xu;Hester Gietema;Harry de Koning;René Vernhout

  • Lead Times and Overdetection Due to Prostate-Specific Antigen Screening

    Gerrit Draisma;Rob Boer;Suzie J. Otto;Ingrid W van der Cruijsen

Frequent Co-Authors

Matthijs Oudkerk
Matthijs Oudkerk University of Groningen
Willem P.Th.M. Mali
Willem P.Th.M. Mali Utrecht University
Harry J.M. Groen
Harry J.M. Groen University Medical Center Groningen
Rob J. de Boer
Rob J. de Boer Utrecht University
Marie-Louise Essink-Bot
Marie-Louise Essink-Bot University of Amsterdam
Jeanne S. Mandelblatt
Jeanne S. Mandelblatt Georgetown University
Mathias Prokop
Mathias Prokop Radboud University
Bram van Ginneken
Bram van Ginneken Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a future in medicine, several related online degrees and alternative career pathways offer flexibility and affordability. One popular option is starting with medical billing and coding classes online. These courses provide foundational knowledge in health data management and can lead to quick entry into the medical field.

Nursing remains a highly sought-after field with a variety of online programs. Prospective nurses can search for how much is online nursing school to compare costs and program options. For those aiming to advance their careers, there are also cheap np programs that prepare registered nurses for specialized, high-demand roles.

Ambitious professionals may also pursue online nursing doctoral programs, opening doors to research, teaching, or leadership positions. Researching these pathways allows students to tailor their education to fit both budget and career goals while supporting the growing needs of the healthcare industry.

Best Scientists Citing Harry J. de Koning

Trending Scientists

Recently Published Articles